| Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects (NCT07584304) | Yuhan Corporation | 2026-07-10 |
| Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers (NCT07470125) | Yuhan Corporation | 2026-06-23 |
| Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines (NCT07415551) | Yuhan Corporation | 2026-03-26 |
| Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects (NCT07265167) | Yuhan Corporation | 2025-10-18 |
| Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis (NCT07111468) | Yuhan Corporation | 2025-08-19 |
| Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects (NCT06920719) | Yuhan Corporation | 2025-06-29 |
| Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors (NCT06975410) | Yuhan Corporation | 2025-06-12 |
| Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects (NCT06926387) | Yuhan Corporation | 2025-04-17 |
| Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers (NCT06775522) | Yuhan Corporation | 2025-01-11 |
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition (NCT06625957) | Yuhan Corporation | 2024-12-04 |
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition (NCT06625931) | Yuhan Corporation | 2024-11-14 |
| Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers (NCT06613139) | Yuhan Corporation | 2024-10-06 |
| Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers (NCT06623526) | Yuhan Corporation | 2024-10-04 |
| A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946 (NCT06616766) | Yuhan Corporation | 2024-10-02 |
| A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants (NCT06517914) | Yuhan Corporation | 2024-07-29 |
| Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers (NCT06359626) | Yuhan Corporation | 2024-06-21 |
| Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension (NCT06041529) | Yuhan Corporation | 2023-10-18 |
| A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases (NCT05960708) | Yuhan Corporation | 2023-08-23 |
| An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS (NCT05835518) | Yuhan Corporation | 2023-01-26 |
| A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease (NCT05730621) | Yuhan Corporation | 2023-01-11 |
| A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases (NCT05564221) | Yuhan Corporation | 2022-11-01 |
| Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor (NCT05523947) | Yuhan Corporation | 2022-08-26 |
| Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation (NCT06247280) | Yuhan Corporation | 2022-06-24 |
| Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension (NCT06282549) | Yuhan Corporation | 2022-06-08 |
| Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers. (NCT05162274) | Yuhan Corporation | 2021-11-30 |
| A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases (NCT05061524) | Yuhan Corporation | 2021-09-26 |
| A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects (NCT05012436) | Yuhan Corporation | 2021-07-24 |
| Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy (NCT04846673) | Yuhan Corporation | 2021-05-14 |
| Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease (NCT06046196) | Yuhan Corporation | 2020-11-18 |
| Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia (NCT06293261) | Yuhan Corporation | 2020-06-27 |
| A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain (NCT05624853) | Yuhan Corporation | 2020-05-12 |
| Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg (NCT04316065) | Yuhan Corporation | 2020-04-11 |
| Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301) (NCT04248829) | Yuhan Corporation | 2020-02-13 |
| BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects (NCT05418803) | Yuhan Corporation | 2020-01-28 |
| Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers (NCT04225052) | Yuhan Corporation | 2019-12-19 |
| Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (NCT03951207) | Yuhan Corporation | 2019-05-30 |
| Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients (NCT03823274) | Yuhan Corporation | 2019-04-01 |
| Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM (NCT03597412) | Yuhan Corporation | 2018-10-17 |
| A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity (NCT03509922) | Yuhan Corporation | 2018-10-11 |
| Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers (NCT03662620) | Yuhan Corporation | 2018-10-05 |
| Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia (NCT03441516) | Yuhan Corporation | 2018-04-19 |
| High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension (NCT03474562) | Yuhan Corporation | 2018-04-03 |
| High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes (NCT03403556) | Yuhan Corporation | 2018-03-27 |
| High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients (NCT03494270) | Yuhan Corporation | 2018-03-18 |
| Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (NCT03446261) | Yuhan Corporation | 2018-02-23 |
| A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients (NCT03334916) | Yuhan Corporation | 2017-10-27 |
| Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension (NCT03267329) | Yuhan Corporation | 2017-09-11 |